Paydirt
MB
Insider

Marcia Belvin

SVP, Chief Scientific Officer

Marcia Belvin (SVP, Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in CTMX. The largest single filing was $202K of CTMX (31,492 sh × $6.42, as filed), executed Mar 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$202K
shares × price, as filed
Last traded
Mar 17
Filed Mar 19
Open performance→
Volume by month
$202K$101K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2026 · sells $202K
Buys $0 Sells $202K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names
CTMX CTMX CTMX · 0 buys · 1 sell 1 filing
Recent filings
CTMXSALE CytomX Therapeutics, Inc. View filing → $202K
31,492 sh × $6.42
Exec Mar 17
Filed Mar 19 · 5:30 PM ET